Paying your bill online is easy.
Wayfinding and parking info
Health Directions offers yoga, pilates, cycling and much more.
Improving the health of our community. A free service.
Schedule an on-site screening to your organization.
Offering programs for your whole health.
Get the info and support you need.
Practical help when you need it most.
Find out what's happening today.
Conveniently-located physician practices.
The largest nursing facility inSouth Carolina.
Exemplary care in a home-like environment.
Urgent Care Centers and outpatient services close to home.
Promoting wellness in the workplace.
You’ll love being a part of our dedicated team.
We recognize the need to educate young students, our future workforce.
Lexington County offers the best of all worlds.
Join our team of committed nurses.
Practice Administrator Fellowship Program details
Services / Cancer Care / Research /
(803) 791-2289(803) 791-2617
(803) 791-25211(800) 635-0858
For more information about cancer-related clinical trials, contact:
Locally available Clinical Trials
A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy (MEC).
An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with HER2 Positive (HER 2+) Metastatic Breast Cancer (SyStHERS)
A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer
Phase 2 Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
A randomized multicenter, double-blind, placebo-controlled comparison of chemotherapy plus trastuzumab plus placebo versus chemotherapy plus trastuzumab plus pertuzumab as adjuvant therapy in patients with operable HER2-positive primary breast cancer
A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less.
A Phase II Study of 5-Fluorouracil, Aflibercept, and Radiation in the Preoperative or Adjuvant Treatment of Patients with Stage II / III Rectal Cancer
A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5 Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab,Oxaliplatin, and a Fluoropyrimidine
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624. Combined with FOLFIRI as Second Line Treatment for Metastatic KRAS or BRAF Mutant Colorectal Adenocarcinoma that Has Progressed Following a First Line Oxaliplatin- andFluoropyrimidine-Containing Regimen.
A phase I study of c-met inhibitor ARQ197 in combination with FOLFOX for the treatment of patients with advanced solid tumors with a phase II portion for patients with previously untreated metastatic gastroesophageal cancer
A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
An Open-Label Randomized Phase III Trial of BMS-936558 Versus Docetaxel in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC).
An Open-label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated Metastatic Non-small Cell Lung Cancer (NSCLC)
An Open Label, Multi-Center IRESSA, Clinical Access Program of Gefitinib 250 mg (Iressa) for the continued treatment of patients in the United States who are currently benefiting or have benefited from Gefitinib treatment
A Randomized, Phase III, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating The Efficacy And Safety Of Metmab In Combination With Tarceva (Erlotinib), In Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer (NSCLC), Who Have Received Standard Chemotherapy For Advanced Or Metastatic Disease.
TOPPS Phase II trial for patients with stage III/IV Non-Small Cell Lung Cancer.
Phase II study for patients with Stage IB, II and III Non-Small-Cell lung cancer.
A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Patients with Advanced Solid Tumors including Extensive Stage Small Cell Lung Cancer.
A Randomized, Double-Blind, Phase III Study of the Efficacy and Safety of Gemcitabine in Combination With TH-302 Compared With Gemcitabine in Combination With Placebo in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Randomized Phase 3 Study Comparing Cabazitaxel/Prednisone in Combination with Custirsen (OGX-011) to Cabazitaxel/Prednisone for Second-Line Chemotherapy in Men with Metastatic Castrate Resistant Prostate Cancer
A Registry of Sipuleucel-T Therapy in Men with Advanced Prostate Cancer.
Lexington Medical Center has launched 3 cancer-related studies based on our tissue banking program
A Phase 3, Randomized, Controlled Study Evaluating the Efficacy and Safety of GS 1101 (CAL-101) in Combination with Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Connect CLL Registry Protocol
An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non- Germinal Center B-Cell like Diffuse Large B-Cell Lymphoma
A Phase III, Multicenter, Randomized Trial Comparing the Efficacy of GA101 in Combination with CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL)
An Open-Label, Multiple Simon 2-Stage Study of INCB039110 Administered Orally to Subjects With Primary Myelofibrosis (PMF), Post Polycythemia Vera-Myelofibrosis (PPVMF) or Post Essential Thrombocythemia-Myelofibrosis (PET-MF)
Phase II Study for the Evaluation of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of patients with Multiple Myeloma Who are not Candidates for High Dose Chemotherapy.
The source for all questions and answers on our site.
We're dedicated to education, support and the promotion of healthy lifestyles.
Serving our community through philanthropy.